Mixed beam measurement method could help make ion cancer therapy more precise

AI Summary

Researchers have developed a mixed-beam measurement method that may improve the precision of ion-beam cancer therapy. The treatment uses accelerated atomic nuclei to target and damage tumors, and is offered at specialized centers including MedAustron in Wiener Neustadt, Austria.

In ion beam therapy, atomic nuclei are accelerated to high energies in a particle accelerator, for example, a synchrotron, and precisely directed at a tumor. There, they damage cancer cells and destroy tumor tissue. This technique is now used at several specialized medical facilities around the world, including MedAustron in Wiener Neustadt, Austria.